biote Corp. appointed Ross W. McQuivey, M.D., as its Chief Medical Officer, effective June 10, 2022. Dr. McQuivey will be responsible for leading continuing clinical research efforts and publications.

The Company also expects that he be instrumental in expanding the Biote Method to mainstream medicine. Dr. McQuivey brings to Biote more than 20 years of medical and scientific leadership in the healthcare industry, with management experience in research and development, medical affairs, as well as regulatory and quality control. He has published over a dozen peer-reviewed journal articles, abstracts and poster presentations, and has lectured extensively in the United States and internationally.

Prior to joining Biote, Dr. McQuivey served as Chief Medical Officer of Laborie Medical Technologies, a global medical technology company focused on urology, urogynecology, gastroenterology, obstetrics, gynecology and neonatal health. He previously held multiple roles of increasing responsibility at Clinical Innovations, LLC, a provider of products for the labor and delivery and neonatal intensive care unit specialties, from 2003 to 2020, with his last position as Chief Medical Officer before the company was acquired. He has held various board positions, including the Journal of Clinical Obstetrics, Gynecology & Infertility, Patient Safety Movement Foundation and the National Patient Safety Council.

Additionally, Dr. McQuivey is a member of the American College of Obstetrics and Gynecology (“ACOG”), the American Medical Association and the Society of Simulation in Healthcare. Previously, he was also a member of the Utah Medical Association and the Utah Section ACOG. Dr. McQuivey earned his Doctor of Medicine from the University of Utah School of Medicine and holds a Bachelor of Arts in psychology from Stanford University.